🚀 VC round data is live in beta, check it out!
Labcorp Valuation Multiples
Discover revenue and EBITDA valuation multiples for Labcorp and similar public comparables like Quest Diagnostics, Mettler Toledo, Sartorius, Exact Sciences and more.
Labcorp Overview
About Labcorp
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.
Founded
1971
HQ
Employees
71.0K
Website
Financials (LTM)
EV
$30B
Labcorp Financials
Labcorp reported last 12-month revenue of $14B and EBITDA of $2B.
In the same LTM period, Labcorp generated $4B in gross profit, $2B in EBITDA, and $1B in net income.
Revenue (LTM)
Labcorp P&L
In the most recent fiscal year, Labcorp reported revenue of $14B and EBITDA of $2B.
Labcorp expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $14B | XXX | $14B | XXX | XXX | XXX |
| Gross Profit | $4B | XXX | $4B | XXX | XXX | XXX |
| Gross Margin | 29% | XXX | 29% | XXX | XXX | XXX |
| EBITDA | $2B | XXX | $2B | XXX | XXX | XXX |
| EBITDA Margin | 17% | XXX | 17% | XXX | XXX | XXX |
| EBIT Margin | 14% | XXX | 14% | XXX | XXX | XXX |
| Net Profit | $1B | XXX | $1B | XXX | XXX | XXX |
| Net Margin | 10% | XXX | 10% | XXX | XXX | XXX |
| Net Debt | — | — | $5B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Labcorp Stock Performance
Labcorp has current market cap of $24B, and enterprise value of $30B.
Market Cap Evolution
Labcorp's stock price is $286.47.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $30B | $24B | 0.0% | XXX | XXX | XXX | $16.71 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialLabcorp Valuation Multiples
Labcorp trades at 2.1x EV/Revenue multiple, and 12.2x EV/EBITDA.
EV / Revenue (LTM)
Labcorp Financial Valuation Multiples
As of March 28, 2026, Labcorp has market cap of $24B and EV of $30B.
Equity research analysts estimate Labcorp's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Labcorp has a P/E ratio of 16.9x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $24B | XXX | $24B | XXX | XXX | XXX |
| EV (current) | $30B | XXX | $30B | XXX | XXX | XXX |
| EV/Revenue | 2.1x | XXX | 2.1x | XXX | XXX | XXX |
| EV/EBITDA | 12.2x | XXX | 12.4x | XXX | XXX | XXX |
| EV/EBIT | 14.5x | XXX | 14.8x | XXX | XXX | XXX |
| EV/Gross Profit | 7.2x | XXX | 7.4x | XXX | XXX | XXX |
| P/E | 16.9x | XXX | 17.1x | XXX | XXX | XXX |
| EV/FCF | 24.3x | XXX | 24.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Labcorp Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Labcorp Margins & Growth Rates
Labcorp's revenue in the last 12 month grew by 5%.
Labcorp's revenue per employee in the last FY averaged $0.2M.
Labcorp's rule of 40 is 22% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Labcorp's rule of X is 30% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Labcorp Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 5% | XXX | 5% | XXX | XXX | XXX |
| EBITDA Margin | 17% | XXX | 17% | XXX | XXX | XXX |
| EBITDA Growth | 7% | XXX | 7% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 22% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 30% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 18% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Labcorp Public Comps
See public comps and valuation multiples for other Laboratory Services and Medical Imaging & Diagnostics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Quest Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Mettler Toledo | XXX | XXX | XXX | XXX | XXX | XXX |
| Sartorius | XXX | XXX | XXX | XXX | XXX | XXX |
| Exact Sciences | XXX | XXX | XXX | XXX | XXX | XXX |
| Natera | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Labcorp M&A Activity
Labcorp acquired XXX companies to date.
Last acquisition by Labcorp was on XXXXXXXX, XXXXX. Labcorp acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Labcorp
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialLabcorp Investment Activity
Labcorp invested in XXX companies to date.
Labcorp made its latest investment on XXXXXXXX, XXXXX. Labcorp invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Labcorp
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Labcorp
| When was Labcorp founded? | Labcorp was founded in 1971. |
| Where is Labcorp headquartered? | Labcorp is headquartered in United States. |
| How many employees does Labcorp have? | As of today, Labcorp has over 71K employees. |
| Who is the CEO of Labcorp? | Labcorp's CEO is Adam H. Schechter. |
| Is Labcorp publicly listed? | Yes, Labcorp is a public company listed on NYSE. |
| What is the stock symbol of Labcorp? | Labcorp trades under LH ticker. |
| When did Labcorp go public? | Labcorp went public in 1988. |
| Who are competitors of Labcorp? | Labcorp main competitors are Quest Diagnostics, Mettler Toledo, Sartorius, Exact Sciences. |
| What is the current market cap of Labcorp? | Labcorp's current market cap is $24B. |
| What is the current revenue of Labcorp? | Labcorp's last 12 months revenue is $14B. |
| What is the current revenue growth of Labcorp? | Labcorp revenue growth (NTM/LTM) is 5%. |
| What is the current EV/Revenue multiple of Labcorp? | Current revenue multiple of Labcorp is 2.1x. |
| Is Labcorp profitable? | Yes, Labcorp is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Labcorp? | Labcorp's last 12 months EBITDA is $2B. |
| What is Labcorp's EBITDA margin? | Labcorp's last 12 months EBITDA margin is 17%. |
| What is the current EV/EBITDA multiple of Labcorp? | Current EBITDA multiple of Labcorp is 12.2x. |
| What is the current FCF of Labcorp? | Labcorp's last 12 months FCF is $1B. |
| What is Labcorp's FCF margin? | Labcorp's last 12 months FCF margin is 9%. |
| What is the current EV/FCF multiple of Labcorp? | Current FCF multiple of Labcorp is 24.3x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.